Radiomics and radiogenomics are used to provide comprehensive tumor biological characte-ristics and further clinical information by extracting, screening and analyzing the most valuable quantitative radiomics features. In recent years, numerous studies have shown that radiomics plays a role in the diagnosis, treatment and predicting efficacy and prognosis of lung cancer. Radiogenomics shows a great value in the prediction of lung cancer gene phenotype and individualized precision treatment by combining radiomics features with genomics, proteomics and so on. Radiomics and radiogenomics are non-invasive, quantitative, and reproducible, and they can provide multidirectional tumor biological characteristics, which are expected to be widely used in the precise medical treatment of lung cancer in the future.
Key words:
Lung neoplasms; Tomography, X-ray computed; Radiomics; Radiogenomics